{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T18:19:26Z","timestamp":1794766766138,"version":"4.9.1"},"posted":{"date-parts":[[2026,6,16]]},"group-title":"Bioengineering","reference-count":33,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>The successful translation of rationally designed HIV-1 immunogens into effective vaccines requires manufacturing platforms that maintain structural conformity while meeting clinical-grade quality standards. We developed and scaled a robust, cGMP-compliant process for N332-GT5 gp140, a germline-targeting envelope trimer designed to initiate broadly neutralizing antibody responses, which is now undergoing first-in-human evaluation in HVTN144. Starting with a stable CHO cell line developed using Leap-In\u00ae transposon technology, we established a production clone exhibiting high-titer expression (&gt;200 mg\/L) and genetic stability through 60 population doublings. The manufacturing process scaled efficiently from Ambr\u00ae 250 miniature bioreactors to 200-L single-use systems, delivering consistent product quality across multiple cGMP batches. A streamlined three-step purification strategy\u2014affinity capture, multimodal polishing, and viral clearance- yielded &gt;99% trimeric purity with preserved quaternary structure and native-like antigenicity. Orthogonal LC-MS analyses confirmed site-specific glycan occupancy matching design specifications, while robust viral clearance exceeded 18-log and 11-log reductions for model retroviruses. Clinical material manufactured through this platform has been successfully administered in HVTN144. This work establishes a scalable, reproducible manufacturing paradigm for structurally complex HIV-1 envelope immunogens, advancing the field toward rational vaccine design based on germline-targeting principles.<\/jats:p>","DOI":"10.64898\/2026.06.11.731363","type":"posted-content","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:55:16Z","timestamp":1781621716000},"source":"Crossref","is-referenced-by-count":1,"title":["Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7973-0332","authenticated-orcid":false,"given":"Sammaiah","family":"Pallerla","sequence":"first","affiliation":[{"name":"IAVI, 125 Broad Street, 9th Floor, New York, NY 10004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaunak","family":"Uplekar","sequence":"additional","affiliation":[{"name":"KBI Biopharma, 4117 Emperor Blvd., Durham, NC 27703"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7380-899X","authenticated-orcid":false,"given":"Ferenc","family":"Boldog","sequence":"additional","affiliation":[{"name":"ATUM Bio, 37950 Central Ct, Newark, CA 94560"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4589-5322","authenticated-orcid":false,"given":"James C.","family":"Paulson","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-5160","authenticated-orcid":false,"given":"Sabyasachi","family":"Baboo","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5267-1672","authenticated-orcid":false,"suffix":"III","given":"John R.","family":"Yates","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hsin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9695-8138","authenticated-orcid":false,"given":"Gabriel","family":"Ozorowski","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2547-968X","authenticated-orcid":false,"given":"Joel D.","family":"Allen","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1072-2694","authenticated-orcid":false,"given":"Max","family":"Crispin","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-3083","authenticated-orcid":false,"given":"Chris","family":"Cottrell","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-3769","authenticated-orcid":false,"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Sitaraman","sequence":"additional","affiliation":[{"name":"ATUM Bio, 37950 Central Ct, Newark, CA 94560"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Broderick","sequence":"additional","affiliation":[{"name":"KBI Biopharma, 4117 Emperor Blvd., Durham, NC 27703"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Costakes","sequence":"additional","affiliation":[{"name":"KBI Biopharma, 4117 Emperor Blvd., Durham, NC 27703"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolette","family":"McCombs","sequence":"additional","affiliation":[{"name":"KBI Biopharma, 4117 Emperor Blvd., Durham, NC 27703"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Ryan","sequence":"additional","affiliation":[{"name":"KBI Biopharma, 4117 Emperor Blvd., Durham, NC 27703"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Wolfe","sequence":"additional","affiliation":[{"name":"KBI Biopharma, 4117 Emperor Blvd., Durham, NC 27703"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Craig","sequence":"additional","affiliation":[{"name":"IAVI, 125 Broad Street, 9th Floor, New York, NY 10004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Syvertsen","sequence":"additional","affiliation":[{"name":"IAVI, 125 Broad Street, 9th Floor, New York, NY 10004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert E.","family":"Price","sequence":"additional","affiliation":[{"name":"IAVI, 125 Broad Street, 9th Floor, New York, NY 10004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4586-3251","authenticated-orcid":false,"given":"Jon M.","family":"Steichen","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, United Kingdom"},{"name":"Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA"},{"name":"IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Schief","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, United Kingdom"},{"name":"Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA"},{"name":"IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA"},{"name":"Center for HIV\/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA"},{"name":"Moderna, Inc., Cambridge, MA 02139, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026061810151688000_2026.06.11.731363v1.1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.1c03059"},{"key":"2026061810151688000_2026.06.11.731363v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.mie.2022.09.004"},{"key":"2026061810151688000_2026.06.11.731363v1.3","doi-asserted-by":"crossref","unstructured":"Bale S , et al. Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysis. npj Vaccines. 2025.","DOI":"10.1038\/s41541-025-01218-6"},{"key":"2026061810151688000_2026.06.11.731363v1.4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01894-16"},{"key":"2026061810151688000_2026.06.11.731363v1.5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055515"},{"key":"2026061810151688000_2026.06.11.731363v1.6","doi-asserted-by":"crossref","unstructured":"Cao L , Diedrich JK , Kulp DW , Pauthner M , He L , Park SR , et al. Global site-specific N-glycosylation analysis of HIV envelope glycoprotein. Nature Communications. 2017;8:14954.","DOI":"10.1038\/ncomms14954"},{"key":"2026061810151688000_2026.06.11.731363v1.7","doi-asserted-by":"publisher","DOI":"10.1002\/bit.26498"},{"issue":"9","key":"2026061810151688000_2026.06.11.731363v1.8","first-page":"e02428","article-title":"Glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers","volume":"91","year":"2017","journal-title":"Journal of Virology"},{"key":"2026061810151688000_2026.06.11.731363v1.9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240604"},{"key":"2026061810151688000_2026.06.11.731363v1.10","unstructured":"HIV Vaccine Trials Network. HVTN 144: A Phase 1 clinical trial to evaluate the safety and immunogenicity of N332-GT5 gp140 adjuvanted with SMNP. ClinicalTrials.gov Identifier: NCT05217641."},{"key":"2026061810151688000_2026.06.11.731363v1.11","first-page":"253","article-title":"Antibodies to the envelope glycoproteins of HIV-1: structure, function, and mechanisms of action","volume":"51","year":"2012","journal-title":"Progress in Lipid Research"},{"key":"2026061810151688000_2026.06.11.731363v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.04.029"},{"key":"2026061810151688000_2026.06.11.731363v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2025.103913"},{"key":"2026061810151688000_2026.06.11.731363v1.14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nmeth.1195","article-title":"A quantitative analysis software tool for mass spectrometry-based proteomics","volume":"5","year":"2008","journal-title":"Nature Methods"},{"key":"2026061810151688000_2026.06.11.731363v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.05.007"},{"key":"2026061810151688000_2026.06.11.731363v1.16","doi-asserted-by":"publisher","DOI":"10.1021\/pr025556v"},{"key":"2026061810151688000_2026.06.11.731363v1.17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/btpr.1874","article-title":"High-throughput miniaturized bioreactors for cell culture process development: reproducibility, scalability, and control","volume":"30","year":"2014","journal-title":"Biotechnology Progress"},{"key":"2026061810151688000_2026.06.11.731363v1.18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adw0721"},{"key":"2026061810151688000_2026.06.11.731363v1.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003618"},{"key":"2026061810151688000_2026.06.11.731363v1.20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4155\/pbp.14.62","article-title":"Viral clearance for biopharmaceutical downstream processes","volume":"3","year":"2015","journal-title":"Pharmaceutical Bioprocessing"},{"key":"2026061810151688000_2026.06.11.731363v1.21","first-page":"eabf1152","article-title":"A stabilized HIV-1 envelope trimer that mimics the native viral spike induces neutralizing antibodies","volume":"6","year":"2021","journal-title":"Science Immunology"},{"key":"2026061810151688000_2026.06.11.731363v1.22","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2020.306138"},{"key":"2026061810151688000_2026.06.11.731363v1.23","doi-asserted-by":"crossref","first-page":"adj8321","DOI":"10.1126\/science.adj8321","article-title":"Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates","volume":"384","year":"2024","journal-title":"Science"},{"key":"2026061810151688000_2026.06.11.731363v1.24","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax4380"},{"key":"2026061810151688000_2026.06.11.731363v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2005.03.010"},{"key":"2026061810151688000_2026.06.11.731363v1.26","doi-asserted-by":"publisher","DOI":"10.1021\/pr015504q"},{"key":"2026061810151688000_2026.06.11.731363v1.27","unstructured":"UNAIDS. Global HIV & AIDS statistics \u2014 2025 fact sheet.https:\/\/www.unaids.org"},{"key":"2026061810151688000_2026.06.11.731363v1.28","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41467-020-16567-0","article-title":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation","volume":"11","year":"2020","journal-title":"Nature Communications"},{"key":"2026061810151688000_2026.06.11.731363v1.29","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.vaccine.2021.05.073","article-title":"Development of a platform-based approach for the clinical production of HIV gp120 envelope glycoprotein vaccine candidates","volume":"39","year":"2021","journal-title":"Vaccine"},{"key":"2026061810151688000_2026.06.11.731363v1.30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jprot.2015.07.001","article-title":"ProLuCID: an improved SEQUEST-like algorithm with enhanced sensitivity and specificity","volume":"129","year":"2015","journal-title":"Journal of Proteomics"},{"key":"2026061810151688000_2026.06.11.731363v1.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.08.016"},{"key":"2026061810151688000_2026.06.11.731363v1.32","doi-asserted-by":"crossref","unstructured":"Parks, et al., Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial. Science Translational Medicine, 30 Jul 2025, Vol 17, Issue 809. DOI: 0.1126\/scitranslmed.ady6831","DOI":"10.1126\/scitranslmed.ady6831"},{"key":"2026061810151688000_2026.06.11.731363v1.33","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4223"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.11.731363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:15:23Z","timestamp":1781802923000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.06.11.731363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":33,"URL":"https:\/\/doi.org\/10.64898\/2026.06.11.731363","relation":{},"subject":[],"published":{"date-parts":[[2026,6,16]]},"subtype":"preprint"}}